Skip to main content
OpenTrials

Clinical trial condition

Colitis

Explore clinical trials studying Colitis. Study availability and eligibility vary by location and protocol.

1,228 public trials 236 recruiting studies
Refine in advanced search Browse all conditions

Colitis trial results

Completed

Efficacy and Safety of Oral BT-11 in Ulcerative Colitis

NCT03861143

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • Axis Clinical Trials Los Angeles, California, United States
  • Ventura Clinical Trials Ventura, California, United States
  • Clinical Research of California Walnut Creek, California, United States
  • Medycal Research Inc. Brooksville, Florida, United States
View all 16 locations
View Trial Details
Completed

Low Dose IL-2 for Ulcerative Colitis

NCT02200445

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Brigham & Women's Hospital Boston, Massachusetts, United States
View Trial Details
Completed

A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis.

NCT03675477

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • Wellness Clinical Research, LLLC-Central Florida Lake Wales, Florida, United States
  • West Central Gastroenterology d/b/a Gastro Florida Tampa, Florida, United States
  • Digestive Disease Specialists, Inc. Oklahoma City, Oklahoma, United States
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
View all 67 locations
View Trial Details
Completed

A Randomized, Multicenter Open Label Study Comparing Early Administration of Azathioprine Plus IFX to Steroids Plus Azathioprine for Acute Severe Colitis

NCT02425852

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • Chu Besancon Besançon, France
  • CHU de CLERMONT FERRAND- Hopital Estain Clermont-Ferrand, France
  • APHP- Hopital BEAUJON Clichy, France
  • Hopital Louis Mourrier Colombes, France
View all 16 locations
View Trial Details
Completed

A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis

NCT01900574

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +5 more
Locations
  • Phoenix, Arizona, United States
  • Los Angeles, California, United States
  • San Francisco, California, United States
  • Hartford, Connecticut, United States
View all 27 locations
View Trial Details

Related conditions